NAICS 4461 · 313 financed acquisitions
$413MCapital deployed
Pharmacies and Drug Stores
313 of these businesses were bought with SBA 7(a) acquisition financing since FY2019. The median carried $1,035,000 of bank debt; the middle half ran $573k to $1.7M. That range is the closest thing to a public price record this part of the market has.
What this is and is not. These figures are loan amounts, not sale prices. A buyer typically funds an acquisition with bank debt plus an equity injection plus, very often, a note from the seller. The SBA file records only its own loan. Read the median here as the debt-financeable portion of a typical deal in this industry, and assume the enterprise value was higher.
Volume and price
What pharmacies and drug stores financed by an SBA 7(a) acquisition loan actually cost, and how many of them there were.
Source: SBA 7(a) FOIA loan-level extract, change-of-ownership approvals, FY2019 onward. Data as of 30 June 2026. n = 313 financed acquisitions.
| Size band | Acquisitions | Share |
|---|---|---|
| Under $250k | 25 | 8.0% |
| $250k to $500k | 42 | 13.4% |
| $500k to $1M | 83 | 26.5% |
| $1M to $2M | 107 | 34.2% |
| $2M to $3.5M | 33 | 10.5% |
| $3.5M to $5M | 19 | 6.1% |
| $5M and above | 4 | 1.3% |
| All | 313 | 100.0% |
The 7(a) programme caps a single loan at $5M, so the top band is a ceiling of the instrument, not of the market. Deals above it are financed conventionally and do not appear in this file at all.
How the paper was structured
Loan terms here are not spread smoothly. They spike at exactly ten years and again at exactly twenty-five, with very little in between. Those two points are the programme's maturity ceilings, and which one applies depends on what secures the loan, so a term running past ten years indicates real property was financed alongside the business.
| Term | What it indicates | Acquisitions | Share |
|---|---|---|---|
| Under 10 years | Shorter than the goodwill maximum | 33 | 10.5% |
| Exactly 10 years | The standard goodwill-only note | 201 | 64.2% |
| 10 to 20 years | Mixed collateral | 64 | 20.4% |
| 20 years and over | Real property financed with the business | 15 | 4.8% |
64.2% of loans here run exactly ten years and 4.8% run twenty years or more. n = 313 loans with a recorded term.
What happened next
Two outcomes are visible in the file: approvals that never funded, and funded loans that later charged off. Both are facts about deals, not forecasts.
The charge-off share is cumulative as of 30 June 2026 for loans approved in FY2019-FY2021. Those loans are five to seven years into terms that are usually ten years, so the figure is a floor and the lifetime rate will be higher. It is not comparable to a rate computed over a fully matured cohort, and the site does not publish one for later years for that reason.
By fiscal year
* FY2026 is incomplete. The extract closes 30 June 2026, nine months into a fiscal year that ends 30 September, and some FY2026 approvals have not yet disbursed. Do not read the last column as a decline.
Concentration
| State | Acquisitions | Share |
|---|---|---|
| CA California | 39 | 12.5% |
| TX Texas | 27 | 8.6% |
| LA Louisiana | 16 | 5.1% |
| NC North Carolina | 15 | 4.8% |
| OH Ohio | 15 | 4.8% |
| WA Washington | 13 | 4.2% |
| MI Michigan | 12 | 3.8% |
| PA Pennsylvania | 12 | 3.8% |
| NY New York | 11 | 3.5% |
| MS Mississippi | 11 | 3.5% |
| Lender | Acquisitions | Share |
|---|---|---|
| Live Oak Banking Company | 95 | 30.4% |
| First Financial Bank | 57 | 18.2% |
| The Huntington National Bank | 7 | 2.2% |
| Bank of Hope | 6 | 1.9% |
| U.S. Bank | 4 | 1.3% |
| Columbia Bank | 4 | 1.3% |
| Wells Fargo Bank | 3 | 1.0% |
| PNC Bank | 3 | 1.0% |
The top lender here wrote 30.4% of the financed acquisitions in this industry. Concentration matters to a seller because a buyer's financing contingency is only as good as the small number of banks that understand the business.
Other industry groups in Retail Trade
If you are selling
Thinking about selling
The figures above describe pharmacies and drug stores at the size the 7(a) programme reaches. They describe a market, not your business. FIH advises owners of privately held companies on sale processes, and the first conversation costs nothing and commits you to nothing.
If you are buying
Register what you are looking for
FIH is an advisory firm that generally acts for sellers, so registering here does not make you a client and no business is listed or offered for sale on this site. It records what you buy, where, at what price you can transact and how a purchase would be funded. It is free, it commits you to nothing, and no deal flow is promised in return.
Figures on this page are SBA loan amounts, not sale prices. Nothing on this site is an offer, a solicitation, a valuation of any business, or investment advice, and no statement here promises a transaction, a price or a result.